Investigational New Drug (IND) Submission checklist

If so, document all possible human risks and indicate how these safety issues will be monitored, or why the risks can be dismissed. ... FDA believes 10 to 15 pages of text with additional tables (as needed) should suffice for the integrated summary. FDA also encourages the use of visual data displays (e.g., box plots, stem and leaf displays ... ................
................